How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer

Today's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values.If you’re a founder, investor, or early hire at a psychedelic company, this episode is a must-listen!In this episode, we discuss:Which psychedelic business models are a good fit for venture capital?Why did Ryan start Vine Ventures?What traits of entrepreneurs does Ryan invest in?Which form of psychedelic medicine is better: natural or synthetic compounds? Links to topics discussed in this episode:PharmauascaOregon Initiative Measure 109ENTHEONPsyGenCalifornia SoberAtaiCompassGet in touch with Ryan Zurrer - TW: @rzurrer LI: Ryan ZurrerRead the transcript here.Watch episode 3 on YouTube.Created by Greg Kubin and Matias SerebrinskyHost: Greg KubinProduced by Jonathan A. DavisFind us at businesstrip.fmFollow us on Instagram and Twitter!Theme music by Dorian LoveAdditional music by Blue Dot Sessions and Chad Crouch